Goals/Scope of the CoP
On December 12, 2012, the CoP on Health began with a group of approximately 15 persons who met to discuss the idea of a community of practice on health and the law. Our members believe the law is an essential tool to meet health objectives and for the optimal operation of any health system. The Cop was formed to build knowledge around questions such as 1. What is the added value of law to the work of development? Is it to have the World Bank integrate law work into its projects or to influence other donors or both? 2. How do we measure and build accountability? 3. What topics should be included? 4. What legal instruments must a MOH be aware of – international agreements and those that are useful to its day to day functioning? 5. What does a human rights framework offer or how does it strengthen results? 6. Your questions? Please let us know!
The concept of community of practice is adopted by the GFLJD to serve as a convening mechanism of sub-sets of the GFLJD members. Membership in the Global Forum is not necessary to be a member of the CoP on Health. All are welcome.
In addition to its substantive events at the annual meeting of the Global
Forum, the COP has been working since 2013 on knowledge products/activities related to falsified and sub-standard medicines and has launched its pilot project in Uganda in 2015.
Designing, funding and implementing a project on law and health; Case study: The Joint Project on Falsified and Substandard Medicines: Legislative, Regulatory and Law Enforcement Solutions
When: November 20, 2015
Where: MC6-100 - World Bank Headquarters, DC
Time: 8:30-10:30 ET
Includes a Member Coffee & Croissant– All are welcome! Networking and to learn about the CoP on Health.
Priority Activities 2014-2017
Design, fund and implement a project on law and health. (completed)
Priority Knowledge Products/Outputs 2014-2017
Our goal is to provide a space to place copies of laws, regulations, policies and other materials relevant to the topic of law, health and development. We are hoping to fill a gap in the online literature on health development and the law that is not already covered by materials on human rights laws.
To submit materials, please send a copy to email@example.com
There are two main sections now that are:
1. Rule of law and health
a. Governance and Rule of Law
b. Structure and function of the ministry of health
c. Public Health
d. Medicines Regulation
e. Health Insurance
2. Legal and Regulatory Aspects of Falsified and Substandard Medicines
Note: the CoP on Health does not endorse or oppose the content of any materials submitted for this LIR. Our goal is to provide a space so these materials can be housed somewhere and accessible to anyone for no charge. Any copyrighted materials must be delivered with permission of the copyright holder if the item is not available freely. Thank you for any contributions.
The Joint Project on Falsified and Substandard Medicines: Legislative, Regulatory and Law Enforcement Solutions
This project is currently being reformatted for scale up to other countries. In the Legal Information Repository the Guide to National Strategy and Assessment Tool can be found for your reference.
Guide to Development of a National Strategy for Strengthening the Legal and Regulatory Environment for the Elimination of Falsified and Substandard Medicines and Assessment Tool to Evaluate National Actions to Address Falsified and Substandard Medicines
Previous Knowledge Products/Activities
October 2 & 3, 2012
Counterfeit Medicines: Impact and Potential Solutions
This knowledge sharing workshop aims to contribute to a multidisciplinary understanding of the global phenomenon of “Counterfeit Medicines” and solutions. For the purpose of this event, we use the WHO definition of Spurious/falsely-labeled/falsified/counterfeit (SFFC) as “medicines are medicines that are deliberately and fraudulently mislabeled with respect to identity and/or source”. The panelists will present and discuss the scale and trend of the phenomenon, its public health and economic impact and the potential solutions from legal, regulatory, technology and enforcement perspectives.
April 17, 2013
Benchmarking Country Action:
The focus of this forum is to examine the use of the Medicrime Convention as a benchmark of international standards, for countries to assess their national laws’ capacity to address the problem of counterfeit medicines. Speakers: Armin Fidler, World Bank, Jan Kleijssen, Council of Europe, Marco Musumeci, UNICRI, and moderator: Michele Forzley, Georgetown Law Center.
A copy of the notes can be obtained here